Yagmur Akdag (Yağmur Akdağ Çaylı)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Cell Proliferation

Photodynamic Therapy

Human Serum Albumin

Top Venues

Pharmaceutical development and technology

This page only lists publications with an associated author ORCID identifier.

Publications

Aslıhan Arslan, Barbaros Yet, Emirhan Nemutlu, Yagmur Akdag, Hakan Eroğlu, Levent Oner
Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Yagmur Akdag
Nanoparticle-containing lyophilized dry powder inhaler formulations optimized using central composite design with improved aerodynamic parameters and redispersibility. Pharmaceutical development and technology 28 (1) (2023)
Aslıhan Arslan, Barbaros Yet, Emirhan Nemutlu, Yagmur Akdag, Hakan Eroğlu, Levent Oner
Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Aslıhan Arslan, Barbaros Yet, Emirhan Nemutlu, Yagmur Akdag, Hakan Eroğlu, Levent Oner
Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Aslıhan Arslan, Barbaros Yet, Emirhan Nemutlu, Yagmur Akdag, Hakan Eroğlu, Levent Oner
Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Yagmur Akdag
Nanoparticle-containing lyophilized dry powder inhaler formulations optimized using central composite design with improved aerodynamic parameters and redispersibility. Pharmaceutical development and technology 28 (1) (2023)
Yagmur Akdag
Nanoparticle-containing lyophilized dry powder inhaler formulations optimized using central composite design with improved aerodynamic parameters and redispersibility. Pharmaceutical development and technology 28 (1) (2023)
Yagmur Akdag
Nanoparticle-Containing Lyophilized Dry Powder Inhaler Formulations Optimized Using Central Composite Design with Improved Aerodynamic Parameters, and Redispersibility. Pharmaceutical development and technology (2023)
Yagmur Akdag
Nanoparticle-containing lyophilized dry powder inhaler formulations optimized using central composite design with improved aerodynamic parameters and redispersibility. Pharmaceutical development and technology (2023)
Tugba Gulsun, Yagmur Akdag, Nihan Izat, Meltem Cetin, Levent Oner, Selma Şahİn
Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tablets. Pharmaceutical development and technology 25 (8) (2020)